China Pharma Holdings, Inc.

CPHIAMEXUSD
0.78 USD
0.02 (2.72%)🟢PRE MARKET (AS OF 04:19 AM EDT)
🟢Market: OPEN

China Pharma Holdings, Inc. (CPHI) trades at $0.78 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, CPHI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Sep 11, 2026.

Open?$0.77
High?$0.78
Low?$0.77
Prev. Close?$0.76
Volume?416
Avg. Volume?768.1K
VWAP?$0.77
Rel. Volume?0.00x
Bid / Ask
Bid?$0.78 × 100
Ask?$0.78 × 100
Spread?$0.00
Midpoint?$0.78
Valuation & Ratios
Market Cap?32.7M
Shares Out?43.0M
Float?2.0M
Float %?4.8%
P/E Ratio?N/A
P/B Ratio?0.90
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A
RelatedUTZ
News
Profile
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Employees
221
Market Cap
32.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2002-04-14
Address
2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, F4 570216
Phone: 8689866811730
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
4
Momentum?
17
Short Sent.?
63
Piotroski F-Score?2/9Weak
Altman Z-Score?0.35Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.98%Elevated
Short Interest?195.8K
Days to Cover?1.0
Free Float2.0M
Avg Daily Volume282.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.26Weak
Quick Ratio?0.08Weak
Cash Ratio?0.04Low
Debt/Equity?0.10Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.90CHEAP
P/S?
Peers
50
S&P
12
8.35HIGH
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
-25.0CHEAP
EV/Sales?
Peers
50
S&P
13
9.20HIGH
Returns & Efficiency
ROE?
S&P
9
-12.4%WEAK
ROA?
S&P
3
-10.0%WEAK
Cash Flow & Enterprise
FCF?$-174182
Enterprise Value?$36.0M
Fundamentals ratios updated end of day